Viewing StudyNCT00054340



Ignite Creation Date: 2024-05-05 @ 11:29 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00054340
Status: COMPLETED
Last Update Posted: 2010-05-14
First Post: 2003-02-05

Brief Title: Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
Sponsor: Fred Hutchinson Cancer Center
Organization: Fred Hutchinson Cancer Center

Conditions & Keywords Data

Conditions:
Name
MyelodysplasticMyeloproliferative Diseases
Chronic Myeloproliferative Disorders
Graft Versus Host Disease
Leukemia
Myelodysplastic Syndromes
Keywords:
Name View
childhood myelodysplastic syndromes View
graft versus host disease View
polycythemia vera View
chronic idiopathic myelofibrosis View
essential thrombocythemia View
untreated adult acute myeloid leukemia View
recurrent adult acute myeloid leukemia View
recurrent childhood acute myeloid leukemia View
untreated childhood acute myeloid leukemia and other myeloid malignancies View
de novo myelodysplastic syndromes View
previously treated myelodysplastic syndromes View
secondary myelodysplastic syndromes View
chronic eosinophilic leukemia View
chronic neutrophilic leukemia View
myelodysplasticmyeloproliferative disease unclassifiable View
adult acute myeloid leukemia with t821q22q22 View
adult acute myeloid leukemia with t1616p13q22 View
adult acute myeloid leukemia with inv16p13q22 View
adult acute myeloid leukemia with 11q23 MLL abnormalities View
adult acute myeloid leukemia with t1517q22q12 View